HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.

Integrative Services in New Jersey, Connecticut, Maryland, and the Washington, DC area

We provide state-of-the-art integrative services for patients with cancer throughout New Jersey, Connecticut, Maryland, and the Washington, DC area. Learn more from Regional Cancer Care Associates.

Read more below about how various integrative services can help you as you receive cancer treatment.

We’re here for you. Call us at 844-346-7222 or

Integrative Services CT, MD, and NJ

Regional Cancer Care Associates are dedicated to providing our patients with the best possible outcomes and highest quality of life through a combination of innovative, state-of-the-art cancer treatments and helpful integrative services. Our experienced cancer specialists understand how important it is to coordinate and integrate care services. Learn more about the integrative services we can offer you at our offices across New Jersey, Connecticut, Maryland. and the Washington, Dc area.

About Our Integrative Services

The cancer specialists at Regional Cancer Care Associates recognize the importance of coordinating care and integrating services to provide the most effective and appropriate treatment. Our team is proud to provide a selection of integrative services that can supplement or enhance a current treatment plan. These services include:

Oncologist explaining to a patient how cancer can affect the body

Side Effects Management

Coping with side effects from cancer and cancer treatments can be challenging and overwhelming. We provide side effect management services to lessen their effect on you and help you manage them.

Palliative Care

Our palliative care services aim to relieve the negative side effects that cancer and cancer treatments can cause, including pain, loss of appetite, nausea, and more. We provide a variety of support services that help treat your symptoms while helping you feel better.

Pharmacy

We have a pharmacy that offers many oral drugs that are reimbursed by insurance as an added convenience for our patients. Medicines are shipped to you efficiently and securely, and co-payments are processed in the same way as they would be at a specialist pharmacy.

Active Surveillance

Active surveillance is part of a cancer treatment plan for patients with low-risk cancer diagnoses, allowing them to maintain a better quality of life and monitor the progress of their cancer with regular analysis and testing.

Integrative Care

Integrative care is part of our holistic, patient-centered philosophy of care and helps to ease the physical and mental burdens of cancer care, maximize your treatment outcome, and improve your overall health and wellbeing.

ADDITIONAL LINKS

Cancer Types

The Many Types of Cancer and Treatment in NJ, CT, MD, and the Washington, D.C., Area Cancer occurs when cells grow uncontrollably. This uncontrolled growth

Read More

Treatments

Where Clinical Expertise Meets Compassion At Regional Cancer Care Associates, we approach your cancer treatment from all angles. Not only do we offer skilled medical

Read More

Clinical Trials

groundbreaking clinical trials in new jersey, connecticut and maryland RCCA is dedicated to the continual improvement of cancer care — from prevention to treatment through

Read More

CONTACT THE CANCER SPECIALISTS AT REGIONAL CANCER CARE ASSOCIATES

Regional Cancer Care Associates aims to support patients with cancer in every step of their cancer journey, including providing advanced medical treatments, helpful resources, and more. We’ve developed our integrative care services to combine medical treatment and therapies that combat the symptoms and side effects of cancer so our patients can reach their optimal health. Contact us today to learn more about our integrative cancer services in CT, MD, and NJ.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.